首页> 外文期刊>Proceedings of the National Academy of Sciences of the United States of America >Complexation of peptidoglycan intermediates by the lipoglycodepsipeptide antibiotic ramoplanin: Minimal structural requirements for intermolecular complexation and fibril formation
【24h】

Complexation of peptidoglycan intermediates by the lipoglycodepsipeptide antibiotic ramoplanin: Minimal structural requirements for intermolecular complexation and fibril formation

机译:脂糖肽肽抗生素雷莫拉宁对肽聚糖中间体的络合:分子间络合和原纤维形成的最低结构要求

获取原文
获取原文并翻译 | 示例
           

摘要

The peptide antibiotic ramoplanin inhibits bacterial peptidoglycan (PG) biosynthesis by interrupting late-stage membrane-associated glycosyltransferase reactions catalyzed by the transglycosylase and MurG enzymes. The mechanism of ramoplanin involves se- questration of lipid-anchored PG biosynthesis intermediates, phys- ically occluding these substrates from proper utilization by these enzymes. In this report, we describe the first molecular-level details of the interaction of ramoplanin with PG biosynthesis intermediates.
机译:肽抗生素雷莫拉宁可通过中断转糖基酶和MurG酶催化的后期膜相关糖基转移酶反应来抑制细菌肽聚糖(PG)的生物合成。雷莫拉宁的作用机制包括螯合脂质锚定的PG生物合成中间体,从物理上阻止这些底物被这些酶正确利用。在这份报告中,我们描述了雷莫普林与PG生物合成中间体相互作用的第一个分子水平的细节。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号